Humanities
Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Journal of Education, Health and Sport

Portal vein thrombosis and non-compliance in a high risk patient – a case study
  • Home
  • /
  • Portal vein thrombosis and non-compliance in a high risk patient – a case study
  1. Home /
  2. Archives /
  3. Vol. 12 No. 6 (2022) /
  4. Case Reports

Portal vein thrombosis and non-compliance in a high risk patient – a case study

Authors

  • Aleksandra Marczak Samodzielny Publiczny Szpital Kliniczny numer 1 w Lublinie https://orcid.org/0000-0002-3025-5907
  • Michalina Hordejuk Wojewódzki Szpital Specjalistyczny w Lublinie https://orcid.org/0000-0003-2473-1062
  • Jakub Gołacki Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie https://orcid.org/0000-0001-8502-3030
  • Klaudia Sapuła Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie https://orcid.org/0000-0003-2436-0150
  • Klaudyna Iwaszko-Sochal Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie https://orcid.org/0000-0001-9228-6138

DOI:

https://doi.org/10.12775/JEHS.2022.12.06.027

Keywords

portal vein thrombosis, polycythemia vera, splenectomy, SARS-CoV-2, non-compliance

Abstract

Portal vein thrombosis is a pathological process that refers to the obstruction of blood flow secondary to thrombus formation. It may be caused by a variety of conditions including cancer, cirrhosis, myeloproliferative neoplasms (eg. polycythemia vera) or surgery in the area of the portal vein (eg. splenectomy). Recent studies suggest that patients with a positive history of SARS-CoV-2 infection have a higher risk of thromboembolic incidents. According to current procedures patients with increased thromboembolic risk should receive anticoagulants. Non-compliance to medical recommendations may develop a disease, directly threatening the patient's health and life. We present a case report of a 69 year old woman with a history of polycythemia vera, recent splenectomy, and SARS-CoV-2 infection who developed massive portal vein thrombosis two days after discontinuation of enoxaparin.

References

Bayraktar Y, Harmanci O. Etiology and consequences of thrombosis in abdominal vessels. World J Gastroenterol. 2006 Feb 28;12(8):1165-74. doi: 10.3748/wjg.v12.i8.1165. PMID: 16534866; PMCID: PMC4124424.

Haris M, Thachil J. Portal vein thrombosis - a primer for the general physician. Clin Med (Lond). 2017 Jun;17(3):212-219. doi: 10.7861/clinmedicine.17-3-212. Erratum in: Clin Med (Lond). 2017 Jul;17 (4):347. Harris M [corrected to Haris M]. PMID: 28572222; PMCID: PMC6297567.

Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol. 2006 Apr 7;12(13):2115-9. doi: 10.3748/wjg.v12.i13.2115. PMID: 16610067; PMCID: PMC4087695.

Stuart BJ, Viera AJ. Polycythemia vera. Am Fam Physician. 2004 May 1;69(9):2139-44. PMID: 15152961.

van't Riet M, Burger JW, van Muiswinkel JM, Kazemier G, Schipperus MR, Bonjer HJ. Diagnosis and treatment of portal vein thrombosis following splenectomy. Br J Surg. 2000 Sep;87(9):1229-33. doi: 10.1046/j.1365-2168.2000.01514.x. PMID: 10971433.

Fujita F, Lyass S, Otsuka K, Giordano L, Rosenbaum DL, Khalili TM, Phillips EH. Portal vein thrombosis following splenectomy: identification of risk factors. Am Surg. 2003 Nov;69(11):951-6. PMID: 14627254.

Franco-Moreno A, Piniella-Ruiz E, Montoya-Adarraga J, Ballano-Franco C, Alvarez-Miguel F, Peinado-Martinez C, Landete-Hernandez E, Saez-Vaquero T, Ulla-Anes M, Torres-Macho J. Portal vein thrombosis in a patient with COVID-19. Thromb Res. 2020 Oct;194:150-152. doi: 10.1016/j.thromres.2020.06.019. Epub 2020 Jun 13. PMID: 32788107; PMCID: PMC7293484.

Rehman A, Thoppil AJ, Wallach SL. Portal Vein Thrombosis and Splenic Infarction in a COVID-19 Patient. Cureus. 2021 Aug 2;13(8):e16843. doi: 10.7759/cureus.16843. PMID: 34513429; PMCID: PMC8410986.

Sogaard, K.K., Astrup, L.B., Vilstrup, H. et al. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol 7, 34 (2007). https://doi.org/10.1186/1471-230X-7-34

Dingli D, Tefferi A. Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia. Curr Hematol Malig Rep. 2006 Jun;1(2):69-74. doi: 10.1007/s11899-006-0025-4. PMID: 20425334.

Tefferi A, Elliott MA, Solberg LA Jr, Silverstein MN. New drugs in essential thrombocythemia and polycythemia vera. Blood Rev. 1997 Mar;11(1):1-7. doi: 10.1016/s0268-960x(97)90001-1. PMID: 9218101.

De Stefano V, Rossi E, Carobbio A, Ghirardi A, Betti S, Finazzi G, Vannucchi AM, Barbui T. Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases. Blood Cancer J. 2018 Nov 12;8(11):112. doi: 10.1038/s41408-018-0151-y. PMID: 30420642; PMCID: PMC6232117.

Gameiro AF, Robalo Nunes A, Guerra P, Mateus E, Fernandes F. Portal Vein Thrombosis Secondary to Occult Polycythemia Vera. Eur J Case Rep Intern Med. 2020 Nov 2;7(12):002003. doi: 10.12890/2020_002003. PMID: 33457359; PMCID: PMC7806286

Downloads

  • PDF

Published

2022-06-24

How to Cite

1.
MARCZAK, Aleksandra, HORDEJUK, Michalina, GOŁACKI, Jakub, SAPUŁA, Klaudia and IWASZKO-SOCHAL, Klaudyna. Portal vein thrombosis and non-compliance in a high risk patient – a case study. Journal of Education, Health and Sport. Online. 24 June 2022. Vol. 12, no. 6, pp. 276-281. [Accessed 28 June 2025]. DOI 10.12775/JEHS.2022.12.06.027.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 12 No. 6 (2022)

Section

Case Reports

License

Copyright (c) 2022 Aleksandra Marczak, Michalina Hordejuk, Jakub Gołacki, Klaudia Sapuła, Klaudyna Iwaszko-Sochal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0

Stats

Number of views and downloads: 499
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

portal vein thrombosis, polycythemia vera, splenectomy, SARS-CoV-2, non-compliance
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop